Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$323.90
al cierre: Aug 21 EDT
$323.40
-0.50-0.15%
Pre-comercialización: 6:30 AM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Tesla Inc ha un obiettivo di prezzo di consenso pari a $311.81, stabilito in base alle ultime valutazioni degli analisti di 29. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wedbush, RBC Capital y China Renaissance il agosto 4, 2025, julio 29, 2025 y julio 25, 2025. Con un obiettivo di prezzo medio di $391.33 tra le Wedbush, RBC Capital y China Renaissance, c'è un implicito 21.01% upside per Tesla Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wedbush
RBC Capital
China Renaissance
GLJ Research
Cantor Fitzgerald
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Tesla
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/04/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/29/2025 | 0.49% | RBC Capital | $319 → $325 | Maintains | Outperform | |||
07/25/2025 | 7.92% | China Renaissance | — | → $349 | Downgrade | Buy → Hold | ||
07/24/2025 | -94.11% | GLJ Research | $19.05 → $19.05 | Reiterates | Sell → Sell | |||
07/24/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/24/2025 | 9.77% | Cantor Fitzgerald | $355 → $355 | Reiterates | Overweight → Overweight | |||
07/24/2025 | — | Needham | — | Maintains | Hold | |||
07/23/2025 | -45.89% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/22/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/21/2025 | 5.44% | B of A Securities | $305 → $341 | Maintains | Neutral | |||
07/11/2025 | -11.87% | Goldman Sachs | $315 → $285 | Maintains | Neutral | |||
07/08/2025 | 15.96% | Mizuho | $390 → $375 | Maintains | Outperform | |||
07/08/2025 | -45.89% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/08/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/07/2025 | — | William Blair | — | Downgrade | Outperform → Market Perform | |||
07/03/2025 | -2.6% | Goldman Sachs | $285 → $315 | Maintains | Neutral | |||
07/03/2025 | -62.89% | HSBC | $120 → $120 | Reiterates | Reduce → Reduce | |||
07/01/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/30/2025 | -6.31% | Canaccord Genuity | $303 → $303 | Maintains | Buy | |||
06/26/2025 | 46.88% | Benchmark | $350 → $475 | Maintains | Buy | |||
06/23/2025 | -45.89% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
06/23/2025 | -33.52% | UBS | $190 → $215 | Maintains | Sell | |||
06/23/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/20/2025 | 54.61% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/11/2025 | 23.69% | Piper Sandler | $400 → $400 | Reiterates | Overweight → Overweight | |||
06/09/2025 | 26.78% | Morgan Stanley | $410 → $410 | Reiterates | Overweight → Overweight | |||
06/09/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
06/09/2025 | -1.05% | Baird | $320 → $320 | Downgrade | Outperform → Neutral | |||
06/06/2025 | -11.87% | Goldman Sachs | $295 → $285 | Maintains | Neutral | |||
05/23/2025 | 54.61% | Wedbush | $350 → $500 | Maintains | Outperform | |||
05/16/2025 | 20.59% | Mizuho | $325 → $390 | Maintains | Outperform | |||
05/06/2025 | -27.33% | Goldman Sachs | $275 → $235 | Reiterates | Neutral → Neutral | |||
05/01/2025 | 8.23% | Wedbush | $350 → $350 | Reiterates | Outperform → Outperform | |||
04/24/2025 | -47.43% | Guggenheim | $170 → $170 | Reiterates | Sell → Sell | |||
04/24/2025 | 39.15% | Stifel | $455 → $450 | Maintains | Buy | |||
04/23/2025 | 8.23% | Benchmark | $350 → $350 | Reiterates | Buy → Buy | |||
04/23/2025 | 0.49% | Mizuho | $375 → $325 | Maintains | Outperform | |||
04/23/2025 | 22.14% | Roth MKM | $450 → $395 | Maintains | Buy | |||
04/23/2025 | -5.07% | RBC Capital | $314 → $307 | Maintains | Outperform | |||
04/23/2025 | -64.44% | JP Morgan | $120 → $115 | Maintains | Underweight | |||
04/23/2025 | 9.77% | Cantor Fitzgerald | $425 → $355 | Maintains | Overweight | |||
04/23/2025 | -6.31% | Canaccord Genuity | $404 → $303 | Maintains | Buy | |||
04/23/2025 | 8.23% | Wedbush | $315 → $350 | Maintains | Outperform | |||
04/23/2025 | -1.05% | Baird | $370 → $320 | Maintains | Outperform | |||
04/23/2025 | -94.11% | GLJ Research | $24.86 → $19.05 | Maintains | Sell | |||
04/23/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/22/2025 | -5.69% | B of A Securities | $380 → $305 | Maintains | Neutral | |||
04/17/2025 | -14.97% | Barclays | $325 → $275 | Maintains | Equal-Weight | |||
04/16/2025 | 23.69% | Piper Sandler | $450 → $400 | Maintains | Overweight | |||
04/10/2025 | -41.25% | UBS | $225 → $190 | Maintains | Sell | |||
04/10/2025 | 15.96% | Mizuho | $430 → $375 | Maintains | Outperform | |||
04/09/2025 | 8.23% | Benchmark | $475 → $350 | Maintains | Buy | |||
04/07/2025 | -2.6% | Wedbush | $550 → $315 | Maintains | Outperform | |||
04/03/2025 | -14.97% | Goldman Sachs | $320 → $275 | Maintains | Neutral | |||
04/03/2025 | -13.42% | Truist Securities | $373 → $280 | Maintains | Hold | |||
04/03/2025 | 31.42% | Cantor Fitzgerald | $425 → $425 | Reiterates | Overweight → Overweight | |||
03/31/2025 | 40.69% | Stifel | $474 → $455 | Maintains | Buy | |||
03/28/2025 | 6.68% | Deutsche Bank | $420 → $345 | Maintains | Buy | |||
03/27/2025 | 70.07% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | 70.07% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | 26.78% | Morgan Stanley | $430 → $410 | Maintains | Overweight | |||
03/20/2025 | 70.07% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/20/2025 | 39.15% | Piper Sandler | $500 → $450 | Maintains | Overweight | |||
03/19/2025 | 31.42% | Cantor Fitzgerald | $425 → $425 | Upgrade | Neutral → Overweight | |||
03/18/2025 | -1.05% | RBC Capital | $440 → $320 | Maintains | Outperform | |||
03/17/2025 | 24.92% | Canaccord Genuity | $404 → $404 | Maintains | Buy | |||
03/17/2025 | 32.96% | Mizuho | $515 → $430 | Maintains | Outperform | |||
03/14/2025 | -59.8% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
03/12/2025 | -62.89% | JP Morgan | $135 → $120 | Maintains | Underweight | |||
03/12/2025 | -47.43% | Guggenheim | $175 → $170 | Maintains | Sell | |||
03/11/2025 | 70.07% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/11/2025 | 24.92% | Canaccord Genuity | $404 → $404 | Maintains | Buy | |||
03/10/2025 | -30.43% | UBS | $259 → $225 | Maintains | Sell | |||
03/07/2025 | 70.07% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/06/2025 | 14.41% | Baird | $440 → $370 | Maintains | Outperform | |||
03/04/2025 | 17.5% | B of A Securities | $490 → $380 | Maintains | Neutral | |||
03/03/2025 | 32.96% | Morgan Stanley | $430 → $430 | Reinstates | → Top Pick | |||
02/25/2025 | — | Guggenheim | — | Reiterates | Sell → Sell | |||
02/12/2025 | 46.88% | Benchmark | → $475 | Initiates | → Buy | |||
02/12/2025 | -92.31% | GLJ Research | $24.86 → $24.86 | Reiterates | Sell → Sell | |||
02/10/2025 | 46.57% | Stifel | $492 → $474 | Maintains | Buy | |||
02/10/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/31/2025 | -45.89% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
01/30/2025 | -19.91% | UBS | $226 → $259 | Maintains | Sell | |||
01/30/2025 | 59.25% | Mizuho | $515 → $515 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 36.05% | RBC Capital | $440 → $440 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 36.05% | Baird | $480 → $440 | Maintains | Outperform | |||
01/30/2025 | 15.34% | Truist Securities | $351 → $373 | Maintains | Hold | |||
01/30/2025 | 31.42% | Cantor Fitzgerald | $365 → $425 | Maintains | Neutral | |||
01/30/2025 | -58.26% | Wells Fargo | $125 → $135 | Maintains | Underweight | |||
01/30/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/29/2025 | -45.89% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
01/29/2025 | 12.86% | Cantor Fitzgerald | $365 → $365 | Reiterates | Neutral → Neutral | |||
01/22/2025 | 70.07% | Wedbush | $515 → $550 | Maintains | Outperform | |||
01/21/2025 | 54.61% | Piper Sandler | $315 → $500 | Maintains | Overweight | |||
01/15/2025 | 0.49% | Barclays | $270 → $325 | Maintains | Equal-Weight | |||
01/13/2025 | 32.96% | Morgan Stanley | $400 → $430 | Maintains | Overweight | |||
01/07/2025 | 51.52% | B of A Securities | $400 → $490 | Downgrade | Buy → Neutral | |||
01/06/2025 | 52.13% | Stifel | $411 → $492 | Maintains | Buy | |||
01/03/2025 | -14.97% | Evercore ISI Group | $195 → $275 | Maintains | In-Line |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Tesla (TSLA)?
El último precio objetivo de Tesla (NASDAQ:TSLA) fue comunicado por Wedbush el agosto 4, 2025. La firma de analistas fijó un precio objetivo para $500.00 que espera TSLA a rise dentro de 12 meses (un posible 54.61% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Tesla (TSLA)?
La última calificación de analistas para Tesla (NASDAQ:TSLA) fue proporcionada por Wedbush, y Tesla reiterado su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Tesla (TSLA)?
La última revisión al alza de Tesla Inc se produjo en marzo 19, 2025, cuando Cantor Fitzgerald elevó su precio objetivo a $425. Cantor Fitzgerald anteriormente tenía a neutral para Tesla Inc.
¿Cuándo fue la última revisión a la baja de Tesla (TSLA)?
La última revisión a la baja de Tesla Inc se produjo en julio 25, 2025, cuando China Renaissance cambió su precio objetivo de N/A a $349 para Tesla Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Tesla (TSLA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Tesla, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Tesla se registró el agosto 4, 2025, por lo que la próxima calificación estará disponible en torno al agosto 4, 2026.
¿Es correcta la calificación de los analistas sobre Tesla (TSLA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Tesla (TSLA) fue un reiterado con un precio objetivo de $500.00 a $500.00. El precio actual al que cotiza Tesla (TSLA) es de $323.40, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.